Skip to main content

Advertisement

Log in

How to explain the role of magnetic resonance imaging on evaluating tumour response of osteosarcoma to neoadjuvant chemotherapy: authors’ reply

  • Letter to the Editor
  • Published:
International Orthopaedics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Jeon D-G, Song WS, Cho WH et al (2014) Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma. Clin Orthop Relat Res 472:1911–1920. doi:10.1007/s11999-014-3521-1

    Article  PubMed Central  PubMed  Google Scholar 

  2. Laux CJ, Berzaczy G, Weber M et al (2014) Tumour response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome. Int Orthop. doi:10.1007/s00264-014-2606-5

    PubMed  Google Scholar 

Download references

Disclosure

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christoph J. Laux.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laux, C.J., Funovics, P.T. How to explain the role of magnetic resonance imaging on evaluating tumour response of osteosarcoma to neoadjuvant chemotherapy: authors’ reply. International Orthopaedics (SICOT) 39, 1451–1452 (2015). https://doi.org/10.1007/s00264-015-2749-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-015-2749-z

Keywords

Navigation